Showing results (1-10 of 203) with videos related to

Sort By:
Pageof 21
Gynecologic Oncology|February 1, 2011
Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experienceG Mangili, C Sigismondi, D Lorusso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2009
Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) GroupD Lorusso, G Ferrandina, S Pignata, et al.
Cancer Treatment Reviews|October 11, 2021
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitorsM Bartoletti, L Musacchio, G Giannone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2003
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patientsD Lorusso, G Ferrandina, S Greggi, et al.
Cancer Chemotherapy and Pharmacology|September 13, 2011
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapyS Pignata, F Amant, G Scambia, et al.
British Journal of Cancer|June 13, 2013
Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovaryG Mangili, J Ottolina, A Gadducci, et al.
Minerva Chirurgica|October 30, 1998
[Does previous gastric resection increase the risks of laparoscopic cholecystectomy? A case-control study]F Pezzolla, D Lorusso
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2016
The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 studyG Mangili, C Sigismondi, D Lorusso, et al.
Annali Italiani Di Chirurgia|July 1, 1998
[Morbidity after video-laparoscopic cholecystectomy in cholelithiasis associated with liver cirrhosis. A case-control study]F Pezzolla, D Lorusso
Oncology|November 29, 2008
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trialS Pignata, G Scambia, A Savarese, et al.
Pageof 21